GlassScriptPhysician profile
Mary Waugh
NPI 1134855281
$4,642.24
in general payments reported to CMS, 2019-2025
18 companies · $1,948 in 2025
The $1,948 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $920 · 2024: $1,775 · 2025: $1,948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,547 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,547.25 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,284.02 | 2023-2025 | |
| Pfizer INC. | $637.54 | 2024-2025 | |
| Amgen INC. | $563.06 | 2024-2025 | Uplizna |
| Emd Serono, INC. | $429.59 | 2023-2025 | Mavenclad, Mavenclad |
| Biogen, INC. | $376.78 | 2023-2025 | Tysabri, Vumerity, Tysabri |
| Novartis Pharmaceuticals Corporation | $354.22 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $231.53 | 2024-2025 | Ultomiris |
| Lilly USA, LLC | $152.96 | 2024 | Kisunla |
| Otsuka America Pharmaceutical, INC. | $124.99 | 2023 | Rexulti |
| Grifols USA, LLC | $110.08 | 2023 | Gamunex-C |
| Lundbeck LLC | $109.14 | 2024-2025 | Vyepti |
| Genzyme Corporation | $94.99 | 2023 | |
| Genentech USA, INC. | $38.12 | 2024-2025 | Ocrevus, Ocrevus Zunovo |
| Jazz Pharmaceuticals INC. | $37.94 | 2025 | |
| Eisai INC. | $30.09 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $26.38 | 2025 | |
| Axsome Therapeutics, INC. | $26.31 | 2025 | Symbravo |
| Sk Life Science, INC. | $14.50 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Waugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.